Weekly Feedback Helps Reduce CT Angiography Radiation Dose
Physicians used significantly lower radiation doses for cardiac CT angiography when weekly dose reports provided feedback on the tests performed.
Weekly dose report feedback of cardiac computed tomography angiography (CCTA) significantly reduces overall radiation doses and reduces the number of high-dose outliers, according to a study published in Academic Radiology.
How CCTA is performed depends on the experience and education of the physicians and technologists performing the exams, which may mean that the ideal radiation doses are not always used. Researchers from Massachusetts General Hospital and Harvard Medical School evaluated real-time feedback by weekly dose reports to see if this would have an effect on everyday practice.
The researchers analyzed 450 patients who underwent physician-supervised CCTA for clinically indicated native coronary evaluation between April 2011 and January 2013. A total of 150 patients were assessed before the initiation of weekly dose report (preintervention period: April to September 2011) and 150 patients after the initiation (postintervention period: September 2011 to February 2012).
Results were compared to a late control group consisting of 150 consecutive CCTA exams, which were performed after the study (September 2012 to January 2013). Patient characteristics and effective radiation were recorded and compared.
The findings showed that the total radiation dose was significantly lower in the postintervention period (3.4 mSv [1.7–5.7] and in the late control group (3.3 mSv [2.0–5.3] versus the preintervention period (4.1 mSv [2.1–6.6] (P = .005).
It was also found that the proportion of high-dose outliers decreased in the postintervention period and late control period (exams with less than 10 mSv were 88.0 percent preintervention versus 97.3 percent postintervention versus 95.3 percent late control.
Exams of less than 15 mSv were:
- Preintervention group: 98 percent
- Postintervention group : 100 percent
- Late control group : 98.7 percent
Exams of less than 20.0 mSv were:
- Preintervention group: 98.7 percent
- Postintervention group: 100 percent
- Late control group: 100.0 percent
The authors concluded that this feedback report helped reduce the exam-related doses and overall dose reductions were maintained beyond the initial study period.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
